BrightSpring Health Services, Inc.
Every calculator, already run for BTSG
Open the full toolkit →You have the numbers on BTSG. Get the argument.
A written report on which of these readings actually decide the outcome for BrightSpring Health Services, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
18 analysts covering BTSGAnalyst Price Target Disagreement for BrightSpring Health Services, Inc.
Wall Street's bull case implies +51% from the current price; the bear case implies +17%. A 34% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Ph…
BTSG — frequently asked
Is BTSG a buy right now?
Wall Street's consensus rating on BrightSpring Health Services, Inc. is Strong Buy across 18 analysts, with a mean price target of $78.94 (+32% vs. the current $59.68). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is BTSG overvalued?
BTSG trades at 53.3x trailing earnings, against a DCF fair value of $71 per share. The current price implies 4% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is BTSG's next earnings date?
BrightSpring Health Services, Inc. is next scheduled to report earnings around Oct 30, 2026. A full BTSG research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for BrightSpring Health Services, Inc.?
Analysts covering BrightSpring Health Services, Inc. (BTSG) range from a bear-case target of $70.00 to a bull-case high of $90.00, with a mean consensus target of $78.94 across 17 analysts. The spread of $20.00 (34% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare BrightSpring Health Services, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For BrightSpring Health Services, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full BTSG research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on BrightSpring Health Services, Inc., in minutes. 3 free reports included with every account — no credit card required.